0001808805-22-000033.txt : 20220331
0001808805-22-000033.hdr.sgml : 20220331
20220331181611
ACCESSION NUMBER: 0001808805-22-000033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220330
FILED AS OF DATE: 20220331
DATE AS OF CHANGE: 20220331
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Akinsanya Karen
CENTRAL INDEX KEY: 0001797672
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39434
FILM NUMBER: 22794909
MAIL ADDRESS:
STREET 1: SCHRODINGER, INC.
STREET 2: 120 WEST 45TH STREET, 17TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc.
CENTRAL INDEX KEY: 0001808805
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-333-2001
MAIL ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III
DATE OF NAME CHANGE: 20200408
4
1
wf-form4_164876493974351.xml
FORM 4
X0306
4
2022-03-30
0
0001808805
Nautilus Biotechnology, Inc.
NAUT
0001797672
Akinsanya Karen
C/O NAUTILUS BIOTECHNOLOGY, INC.
2701 EASTLAKE AVENUE EAST
SEATTLE
WA
98102
1
0
0
0
Stock Option (Right to Buy)
4.24
2022-03-30
4
A
0
105998
0
A
2032-03-30
Common Stock
105998.0
105998
D
In connection with the appointment of the Reporting Person to the Issuer's board of directors (the "Board") on March 30, 2022, the Reporting Person automatically received the Option (the "Initial Award") under the Issuer's Outside Director Compensation Policy and in accordance with the Issuer's 2021 Equity Incentive Plan (the "Plan"). Subject to the Reporting Person's continuous status as a "Service Provider" (as defined in the Plan), the Initial Award is scheduled to vest as to one thirty-sixth (1/36th) of the shares of common stock subject to the Initial Award on a monthly basis following the Initial Award's grant date on the same day of the month as such grant date (or on the last day of the month, if there is no corresponding day in such month). The grant date is March 30, 2022.
/s/ Matthew B. Murphy, as Attorney-in-Fact
2022-03-31